238 related articles for article (PubMed ID: 32976029)
1. Role of indoleamine 2,3-dioxygenase in acute myeloid leukemia.
Sobash PT; Kolhe R; Karim NA; Guddati AK; Jillella A; Kota V
Future Oncol; 2020 Dec; 16(36):3085-3094. PubMed ID: 32976029
[TBL] [Abstract][Full Text] [Related]
2. Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review.
Wells G; Kennedy PT; Dahal LN
Front Immunol; 2021; 12():651687. PubMed ID: 33777052
[No Abstract] [Full Text] [Related]
3. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM
Haematologica; 2010 Dec; 95(12):2022-30. PubMed ID: 20801903
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2,3-dioxygenase in transplantation.
Mulley WR; Nikolic-Paterson DJ
Nephrology (Carlton); 2008 Jun; 13(3):204-11. PubMed ID: 18221253
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.
Belladonna ML; Puccetti P; Orabona C; Fallarino F; Vacca C; Volpi C; Gizzi S; Pallotta MT; Fioretti MC; Grohmann U
Transplantation; 2007 Jul; 84(1 Suppl):S17-20. PubMed ID: 17632406
[TBL] [Abstract][Full Text] [Related]
6. [Indoleamine 2, 3-dioxygenase activity in acute myeloid leukemia cells contributing to tumor immune escape].
Tang XQ; Zhao ZG; Wang HX; Li QB; Lü J; Zou P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun; 14(3):539-42. PubMed ID: 16800938
[TBL] [Abstract][Full Text] [Related]
7. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells.
Curti A; Pandolfi S; Valzasina B; Aluigi M; Isidori A; Ferri E; Salvestrini V; Bonanno G; Rutella S; Durelli I; Horenstein AL; Fiore F; Massaia M; Colombo MP; Baccarani M; Lemoli RM
Blood; 2007 Apr; 109(7):2871-7. PubMed ID: 17164341
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2, 3-Dioxygenase Promotes Aryl Hydrocarbon Receptor-Dependent Differentiation Of Regulatory B Cells in Lung Cancer.
Tousif S; Wang Y; Jackson J; Hough KP; Strenkowski JG; Athar M; Thannickal VJ; McCusker RH; Ponnazhagan S; Deshane JS
Front Immunol; 2021; 12():747780. PubMed ID: 34867973
[TBL] [Abstract][Full Text] [Related]
9. Expression of indoleamine 2,3-dioxygenase in acute myeloid leukemia and the effect of its inhibition on cultured leukemia blast cells.
El Kholy NM; Sallam MM; Ahmed MB; Sallam RM; Asfour IA; Hammouda JA; Habib HZ; Abu-Zahra F
Med Oncol; 2011 Mar; 28(1):270-8. PubMed ID: 20300979
[TBL] [Abstract][Full Text] [Related]
10. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.
Katz JB; Muller AJ; Prendergast GC
Immunol Rev; 2008 Apr; 222():206-21. PubMed ID: 18364004
[TBL] [Abstract][Full Text] [Related]
11. Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.
Johnson TS; Munn DH
Immunol Invest; 2012; 41(6-7):765-97. PubMed ID: 23017145
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-dioxygenase activity of acute myeloid leukemia cells can be measured from patients' sera by HPLC and is inducible by IFN-gamma.
Corm S; Berthon C; Imbenotte M; Biggio V; Lhermitte M; Dupont C; Briche I; Quesnel B
Leuk Res; 2009 Mar; 33(3):490-4. PubMed ID: 18639339
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3-dioxygenase and regulatory function: tryptophan starvation and beyond.
Orabona C; Grohmann U
Methods Mol Biol; 2011; 677():269-80. PubMed ID: 20941617
[TBL] [Abstract][Full Text] [Related]
14. Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy.
Yentz S; Smith D
BioDrugs; 2018 Aug; 32(4):311-317. PubMed ID: 29980987
[TBL] [Abstract][Full Text] [Related]
15. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
16. Expression of indoleamine 2,3-dioxygenase in leukemic cells indicates an unfavorable prognosis in acute myeloid leukemia patients with intermediate-risk cytogenetics.
Fukuno K; Hara T; Tsurumi H; Shibata Y; Mabuchi R; Nakamura N; Kitagawa J; Shimizu M; Ito H; Saito K; Moriwaki H
Leuk Lymphoma; 2015 May; 56(5):1398-405. PubMed ID: 25248875
[TBL] [Abstract][Full Text] [Related]
17. Role of indoleamine 2,3-dioxygenase in testicular immune-privilege.
Gualdoni GS; Jacobo PV; Sobarzo CM; Pérez CV; Matzkin ME; Höcht C; Frungieri MB; Hill M; Anegon I; Lustig L; Guazzone VA
Sci Rep; 2019 Nov; 9(1):15919. PubMed ID: 31685866
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase and regulatory T cells in acute myeloid leukemia.
Mansour I; Zayed RA; Said F; Latif LA
Hematology; 2016 Sep; 21(8):447-53. PubMed ID: 27077762
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.
Schafer CC; Wang Y; Hough KP; Sawant A; Grant SC; Thannickal VJ; Zmijewski J; Ponnazhagan S; Deshane JS
Oncotarget; 2016 Nov; 7(46):75407-75424. PubMed ID: 27705910
[TBL] [Abstract][Full Text] [Related]
20. Role of tryptophan metabolism in cancers and therapeutic implications.
Liu XH; Zhai XY
Biochimie; 2021 Mar; 182():131-139. PubMed ID: 33460767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
